ZA200805563B - Stable pharmaceutical formulation of an acid labile compound and process for preparing the same - Google Patents

Stable pharmaceutical formulation of an acid labile compound and process for preparing the same

Info

Publication number
ZA200805563B
ZA200805563B ZA200805563A ZA200805563A ZA200805563B ZA 200805563 B ZA200805563 B ZA 200805563B ZA 200805563 A ZA200805563 A ZA 200805563A ZA 200805563 A ZA200805563 A ZA 200805563A ZA 200805563 B ZA200805563 B ZA 200805563B
Authority
ZA
South Africa
Prior art keywords
preparing
same
pharmaceutical formulation
acid labile
stable pharmaceutical
Prior art date
Application number
ZA200805563A
Other languages
English (en)
Inventor
Ghosh Pradip
Mukherji Gour
Original Assignee
Jubilant Organosys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Organosys Ltd filed Critical Jubilant Organosys Ltd
Publication of ZA200805563B publication Critical patent/ZA200805563B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200805563A 2006-01-16 2008-06-25 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same ZA200805563B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN114DE2006 2006-01-16

Publications (1)

Publication Number Publication Date
ZA200805563B true ZA200805563B (en) 2009-11-25

Family

ID=37847220

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805563A ZA200805563B (en) 2006-01-16 2008-06-25 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same

Country Status (6)

Country Link
US (1) US8865212B2 (fr)
EP (1) EP1973532A1 (fr)
JP (1) JP2009523784A (fr)
BR (1) BRPI0621024A2 (fr)
WO (1) WO2007080601A1 (fr)
ZA (1) ZA200805563B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3207921A1 (fr) 2007-09-14 2017-08-23 Wockhardt Limited Compositions de rhéine ou diacéréine
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
RU2015141706A (ru) * 2013-03-01 2017-04-06 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи. Пленочные покрытия с отсроченным высвобождением, содержащие силикат кальция, и субстраты, покрытые ими
JP6360881B2 (ja) 2013-03-22 2018-07-18 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 触媒的ｍｔｏｒｃ１／２阻害薬及びオーロラａキナーゼの選択的阻害薬の組合せ
ES2929218T3 (es) * 2015-01-12 2022-11-28 Enteris Biopharma Inc Formas farmacéuticas orales sólidas
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018052290A1 (fr) * 2016-09-15 2018-03-22 Stichting Het Nederlands Kanker Instituut Pyrophosphate oral destiné à être utilisé dans la réduction de la calcification des tissus
WO2018065952A1 (fr) * 2016-10-06 2018-04-12 Jubilant Generics Limited Composition pharmaceutique de pantoprazole à action retardée et son procédé de préparation
TR201701461A2 (tr) * 2017-01-31 2018-08-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dekslansoprazolün Enterik Kaplı Farmasötik Kompozisyonları
KR102494141B1 (ko) * 2019-10-18 2023-02-01 주식회사 대웅테라퓨틱스 프로톤 펌프 저해제 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6602522B1 (en) 1997-11-14 2003-08-05 Andrx Pharmaceuticals L.L.C. Pharmaceutical formulation for acid-labile compounds
GB0307367D0 (en) * 2003-03-29 2003-05-07 Twg Composition and method for treating the gastro-intestinal tract
EP1651193A2 (fr) * 2003-07-17 2006-05-03 Dr. Reddy's Laboratories, Inc. Compositions pharmaceutiques a revetement gonflant
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2006111853A2 (fr) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Formes posologiques solides stables d'un medicament labile en milieu acide

Also Published As

Publication number Publication date
BRPI0621024A2 (pt) 2011-11-29
WO2007080601A1 (fr) 2007-07-19
US8865212B2 (en) 2014-10-21
EP1973532A1 (fr) 2008-10-01
US20090022795A1 (en) 2009-01-22
JP2009523784A (ja) 2009-06-25

Similar Documents

Publication Publication Date Title
ZA200805563B (en) Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
IL250937A0 (en) Pharmaceutical preparations and kits containing sphingomyelinase acid
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL196280A0 (en) Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
EP2076244A4 (fr) Systèmes aqueux pour la préparation de composés pharmaceutiques à base lipidique et leurs compositions, procédés et utilisations
ME02026B (fr) Nouvelle forme cristalline V de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
EP2078731A4 (fr) Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
ZA200902451B (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
EP2277861A4 (fr) Dérivé d ester d acide (amine cyclique)-1-carboxylique et composition pharmaceutique le contenant
ZA201100428B (en) Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
HK1155733A1 (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof 4----1-
EP2214680A4 (fr) Formulation pharmaceutique de l'acide clavulanique
EP2212325A4 (fr) Dérivé d' ester d'acide 2-arylméthylazetidine-carbapenem-3-carboxylique ou sels de ce dérivé, processus de préparation de ce composé et composition pharmaceutique le comprenant
EP2196463A4 (fr) Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci
EP2098237A4 (fr) Agent analgésique comprenant un dérivé cyclique d'acide phosphatidique
IL203064B (en) Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
IL194094A0 (en) Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives
IL176870A0 (en) Solid forms of montelukast acid, pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
IL213792A0 (en) Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same